Pentoxifylline Tablet, Extended Release
Product Images NDC 0615-8511

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentoxifylline (NDC 0615-8511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Pentoxifylline Er Tabs 8511 1)

Chemical structure of pentoxifylline, showing the molecular formula C13H18N4O3 and molecular weight 278.31. The diagram depicts the arrangement of atoms and bonds within the pentoxifylline molecule.*

FDA Label Image

Ani-logo (Pentoxifylline Er Tabs 8511 2)

FDA Label Image

Principal Display Panel (Pentoxifylline Er Tabs 8511 3)

Label for Pentoxifylline Extended-Release Tablets USP 400 mg, oral tablets. The label indicates a quantity of 30 tablets with the lot number 8511-. Manufactured by Novitium Pharma for ANI Pharmaceuticals and packaged by Vangard Labs, Glasgow, KY. The label includes storage instructions to keep the product at 20° to 25°C and a note for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.